Sei Investments Co. Acquires 57,948 Shares of InfuSystem Holdings, Inc. $INFU

Sei Investments Co. boosted its holdings in InfuSystem Holdings, Inc. (NYSE:INFU) by 123.8% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 104,757 shares of the company’s stock after acquiring an additional 57,948 shares during the quarter. Sei Investments Co. owned 0.52% of InfuSystem worth $967,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP grew its holdings in InfuSystem by 6.0% during the first quarter. Dimensional Fund Advisors LP now owns 594,288 shares of the company’s stock worth $5,486,000 after buying an additional 33,410 shares in the last quarter. Heartland Advisors Inc. boosted its holdings in InfuSystem by 2.0% during the 1st quarter. Heartland Advisors Inc. now owns 510,000 shares of the company’s stock worth $4,707,000 after acquiring an additional 10,000 shares during the last quarter. Hillsdale Investment Management Inc. boosted its holdings in InfuSystem by 1.1% during the 1st quarter. Hillsdale Investment Management Inc. now owns 452,373 shares of the company’s stock worth $4,175,000 after acquiring an additional 5,000 shares during the last quarter. Hsbc Holdings PLC grew its stake in shares of InfuSystem by 5.7% in the 1st quarter. Hsbc Holdings PLC now owns 30,097 shares of the company’s stock worth $281,000 after acquiring an additional 1,619 shares in the last quarter. Finally, North Star Investment Management Corp. grew its stake in shares of InfuSystem by 527.6% in the 1st quarter. North Star Investment Management Corp. now owns 182,000 shares of the company’s stock worth $1,680,000 after acquiring an additional 153,000 shares in the last quarter. 71.13% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Separately, B. Riley Financial reissued a “buy” rating and set a $20.00 price target (up from $12.00) on shares of InfuSystem in a research report on Wednesday, August 5th. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $16.67.

InfuSystem Stock Performance

Shares of INFU opened at $12.24 on Thursday. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $247.03 million, a price-to-earnings ratio of 204.03 and a beta of 1.42. The stock has a 50 day moving average of $9.73 and a 200 day moving average of $9.34. InfuSystem Holdings, Inc. has a 12 month low of $7.29 and a 12 month high of $12.97.

InfuSystem announced that its board has initiated a share repurchase program on Tuesday, May 19th that authorizes the company to buyback $20.00 million in shares. This buyback authorization authorizes the company to reacquire up to 10.2% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board believes its stock is undervalued.

About InfuSystem

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.